Real-time enrollment status for this acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 3:50 PM UTC
| NCT Number | NCT07227584 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 67 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT07227584 is currently recruiting participants. This phase2 study for acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227584 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227584 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.